98%
921
2 minutes
20
Syndecan-1 (Sdc-1) is a heparan sulfate proteoglycan that can bind cytokines and chemokines via its heparan sulfate side chains, and has immunomodulatory properties in experimental models. Sdc-1 expression has been reported on dendritic cells (DC) and T cells. The potential role of Sdc-1 in DC-T cell interaction has not been investigated yet. We postulate that Sdc-1 is involved in DC-T cell interaction and may influence graft survival in an allogeneic transplant model. Sdc-1 expression on bone marrow-derived DC and T cells was analyzed by flow cytometry. Unstimulated and LPS stimulated Sdc-1 deficient DC were evaluated in vitro for phenotype and stimulatory capacity in mixed lymphocyte reaction. Sdc-1 deficient T cells were evaluated for proliferative capacity and differentiation in a mixed lymphocyte reaction and a proliferation assay. Allograft survival was evaluated in a fully MHC mismatched heterotopic heart transplant model, with either Sdc-1 deficient donors or recipients. Sdc-1 was expressed on the cell surface of unstimulated and LPS matured DC. Sdc-1 deficiency had no effect on expression of co-stimulatory molecules, cytokine production or T cell stimulatory capacity as compared to WT DC. Sdc-1 expression was not detectable on WT T cells, although intracellular Sdc-1 expression could be demonstrated after ConA activation. Sdc-1 deficient T cells showed reduced proliferation upon DC or ConA stimulation and reduced IL-17 production upon ConA stimulation, compared to WT T cells. Sdc-1 deficiency of either allograft or recipient did not prolong allograft survival. In conclusion, Sdc-1 is expressed on the cell surface of DC, where its absence does not affect DC phenotype or T cell stimulatory capacity. Sdc-1 is intracellularly expressed in ConA activated T cells. Sdc-1 deficiency in T cells results in a reduced proliferative response in vitro, as induced by DC and ConA. Sdc-1 deficiency in donor or recipient does not affect allograft survival.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377417 | PMC |
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0230835 | PLOS |
Burns
July 2025
Firefighters' Burn and Surgical Research Laboratory, MedStar Health Research Institute, Washington, DC, United States; Departments of Surgery and Biochemistry, Georgetown University School of Medicine, Washington, DC, United States; The Burn Center, MedStar Washington Hospital Center, Washington, DC
Introduction: Burn shock is mediated by a complex inflammatory response leading to endothelial cell dysfunction (EnD) and increased vascular permeability in large total body surface area (TBSA) injuries. Smaller TBSA burns do not induce systemic EnD. Previous studies in animal models have examined systemic markers of endothelial cell dysfunction following thermal injury and have aimed to characterize this dysfunction in various end organs.
View Article and Find Full Text PDFZhonghua Wei Zhong Bing Ji Jiu Yi Xue
June 2025
Department of Critical Care Medicine, Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, Zhejiang, China. Tang Zewen now works in the emergency department of Zhuzhou Central Hospital, Zhuzhou 412007, Hunan, China. Corresponding author: Lin Leqing, Email:
Objective: To explore the protective effect of glycosaminoglycans (GAG) on vascular endothelium in patients with sepsis.
Methods: A prospective study was conducted on adult patients with sepsis admitted to the intensive care unit (ICU) of Hangzhou Normal University Affiliated Hospital from December 2022 to December 2023. Patients were randomly divided into conventional treatment group and GAG intervention group.
Metabolism
November 2025
Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China; Department of Nephrology, Zhongshan Hospital, Shanghai Medical Center for Kidney, Shanghai, China; Department of Nephrology, Zhongshan Hospital, Shanghai Key Laboratory of Kidney and Blood Purification, Shanghai, China;
Background: The transition from acute kidney injury (AKI) to chronic kidney disease (CKD) is characterized by persistent renal fibrosis, in which abnormal lipid metabolism plays a crucial role. Syndecan-1 (SDC-1) has been implicated in various tissue remodeling processes; however, its role in lipid metabolism and fibrosis during the progression from AKI to CKD is not well understood.
Methods: This study used a murine model of unilateral ischemia-reperfusion-induced AKI-to-CKD progression for in vivo analysis and employed transforming growth factor-beta (TGF-β)-induced fibrosis in Human Kidney-2 cells and primary mouse tubular epithelial cells for in vitro studies.
Schizophr Res
September 2025
Jagiellonian University, Jagiellonian Centre for Experimental Therapeutics (JCET), 30-348 Krakow, Poland; Jagiellonian University, Jagiellonian University Medical College, Chair of Pharmacology, 31-531 Krakow, Poland. Electronic address:
Impaired endothelial function in patients with psychotic disorders may contribute to increased cardiovascular mortality, but the mechanisms involved remain unclear. Here, we comprehensively analyzed endothelial function in 33 young (median age 18: IQR 17-27) patients diagnosed with first-episode psychosis (FEP), examining large vessels (flow-mediated dilation; FMD) and the microcirculation in peripheral vessels (peripheral arterial tonometry following reactive hyperemia; RH-PAT) and in the skin (flow-mediated skin fluorescence; FMSF). We also measured the plasma concentration of nitric oxide (NO) metabolites (nitrite/nitrate) and 18 biomarkers related to endothelial function, including those representative of glycocalyx damage (SDC-1), endothelial inflammation (sVCAM-1), disrupted endothelial permeability (Angpt-1, Angpt-2), and hemostasis (TAFI, THBS-1).
View Article and Find Full Text PDFEndocrine
July 2025
Department of Endocrinology, Diabetes and Metabolism, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Purpose: Diabetes as common comorbidity is associated with an impaired outcome for inpatients. Inadequate transition of dysglycemia specific information from hospital to outpatient setting may disrupt continuity of care and contribute to impaired patient outcome. We tested whether a digitalized diabetes management improves awareness of in-hospital health care professionals for diabetes as comorbidity.
View Article and Find Full Text PDF